Literature DB >> 29511590

Primary high grade testicular leiomyosarcoma: A rare malignancy in a young male.

Fouzia Siraj1, Shruti Sharma1, Chandra Bhushan Rai1, Pawan Vasudeva2.   

Abstract

A 27-year-old male presented with a gradually increasing left scrotal mass. There was no significant past medical history. Ultrasonography of the left scrotum showed a hypoechoic, intratesticular mass with solid and cystic components. Laboratory investigations revealed normal serum levels of alpha-fetoprotein, beta human chorionic gonadotropin and lactate dehydrogenase. He underwent left high inguinal orchidectomy due to suspicion of testicular malignancy. After histopathologic examination and immunostaining, a diagnosis of high-grade primary testicular leimyosarcoma was ascertained. Only a few cases of primary intratesticular leiomyosarcoma have been reported in literature with the mean age of presentation of 50 years. In younger individuals, these tumors have been reported in a setting of predisposing factors like anabolic steroid use, testicular germ cell tumors, chronic inflammation of testis and testicular field radiation for treatment of leukemia. We present a case of high grade leiomyosarcoma of testis in a young male without any known predisposing factors.

Entities:  

Keywords:  Immunohistochemistry; leiomyosarcoma; sarcoma; testis

Year:  2017        PMID: 29511590      PMCID: PMC5832382          DOI: 10.5152/tud.2017.15821

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  10 in total

Review 1.  Primary low grade intratesticular leiomyosarcoma: case report and review of the literature.

Authors:  Samir Abdullazade; Onder Kara; Bülent Akdoğan; Dilek Ertoy Baydar
Journal:  Turk Patoloji Derg       Date:  2013

2.  Renal leiomyosarcoma with soft tissue metastasis: An unusual presentation.

Authors:  Varsha Narula; Fouzia Siraj; Anju Bansal
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

3.  Primary intratesticular pleomorphic leiomyosarcoma: a rare case report.

Authors:  Rajshri Pisaram Damle; Kishor H Suryawanshi; Nandkumar V Dravid; Dhananjay V Newadkar
Journal:  Indian J Pathol Microbiol       Date:  2013 Oct-Dec       Impact factor: 0.740

Review 4.  Postradiotherapy intratesticular leiomyosarcoma.

Authors:  Benjamin K Canales; Stephen J Lukasewycz; Juan C Manivel; Jon L Pryor
Journal:  Urology       Date:  2005-09       Impact factor: 2.649

5.  Intratesticular leiomyosarcoma in a young man after high dose doping with Oral-Turinabol: a case report.

Authors:  M Froehner; R Fischer; S Leike; O W Hakenberg; B Noack; M P Wirth
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

6.  Primary intratesticular leiomyosarcoma in a mixed race man: a case report.

Authors:  R Singh; A Chandra; T S O'Brien
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

7.  [A case report of testicular leiomyosarcoma].

Authors:  H Hachi; A Bougtab; R Amhajji; F Otmany; A al Bouzidi; L Laalou; M Bellabas; S Benjelloun
Journal:  Med Trop (Mars)       Date:  2002

8.  Leiomyosarcoma complicating chronic inflammation of the testis.

Authors:  Y Ali; E O Kehinde; R Makar; K A Al-Awadi; J T Anim
Journal:  Med Princ Pract       Date:  2002 Jul-Sep       Impact factor: 1.927

9.  Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.

Authors:  Hugo Domínguez Malagón; Ana María Cano Valdez; Cesar A Moran; Saul Suster
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394

10.  Primary high-grade testicular leiomyosarcoma.

Authors:  Mohan Kumar; Shashikant C U Patne; Sandip Kumar; V K Shukla
Journal:  Indian J Pathol Microbiol       Date:  2009 Jan-Mar       Impact factor: 0.740

  10 in total
  1 in total

1.  Clinical Characteristics and Prognostic Factors of Testicular Sarcoma: A Population-Based Study.

Authors:  Xingyuan Wang; Zeyu Chen; Shi Qiu; Dehong Cao; Kun Jin; Jin Li; Bo Chen; Haoran Lei; Yin Huang; Yige Bao; Lu Yang; Liangren Liu; Qiang Wei
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.